The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Treclin 10 mg/g + 0.25 mg/g Gel

Mylan IRE Healthcare LimitedPA2010/044/001

Main Information

Trade NameTreclin 10 mg/g + 0.25 mg/g Gel
Active SubstancesClindamycin
Dosage FormGel
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/044/001

Group Information

ATC CodeD10AF Antiinfectives for treatment of acne
D10AF01 clindamycin


License statusAuthorised
Licence Issued22/03/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis medicinal product should be given to women of childbearing potential only if effective contraception is used during treatment and for 1 month after discontinuation of treatment. This medicinal product should not be used in pregnancy, especially during the first trimester, and in women who may become pregnant. This medicinal product should not be used in women who are breast feeding.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back